- Home
- NTZ vs CCEL Comparison
NTZ vs CCEL Comparison
Compare NTZ & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- CCEL
- Stock Information
- Founded
- NTZ 1959
- CCEL 1989
- Country
- NTZ Italy
- CCEL United States
- Employees
- NTZ N/A
- CCEL N/A
- Industry
- NTZ Home Furnishings
- CCEL Managed Health Care
- Sector
- NTZ Consumer Discretionary
- CCEL Health Care
- Exchange
- NTZ Nasdaq
- CCEL Nasdaq
- Market Cap
- NTZ 41.6M
- CCEL 39.9M
- IPO Year
- NTZ 1993
- CCEL 1997
- Fundamental
- Price
- NTZ $3.25
- CCEL $4.83
- Analyst Decision
- NTZ
- CCEL Strong Buy
- Analyst Count
- NTZ 0
- CCEL 1
- Target Price
- NTZ N/A
- CCEL $8.50
- AVG Volume (30 Days)
- NTZ 1.8K
- CCEL 13.1K
- Earning Date
- NTZ 07-02-2025
- CCEL 07-22-2025
- Dividend Yield
- NTZ N/A
- CCEL 20.62%
- EPS Growth
- NTZ N/A
- CCEL N/A
- EPS
- NTZ N/A
- CCEL 0.01
- Revenue
- NTZ $337,653,480.00
- CCEL $32,102,750.00
- Revenue This Year
- NTZ N/A
- CCEL $2.49
- Revenue Next Year
- NTZ N/A
- CCEL $0.95
- P/E Ratio
- NTZ N/A
- CCEL $303.41
- Revenue Growth
- NTZ N/A
- CCEL 2.33
- 52 Week Low
- NTZ $3.04
- CCEL $4.75
- 52 Week High
- NTZ $6.27
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- NTZ 31.63
- CCEL 40.85
- Support Level
- NTZ $3.25
- CCEL $4.80
- Resistance Level
- NTZ $3.32
- CCEL $6.35
- Average True Range (ATR)
- NTZ 0.05
- CCEL 0.26
- MACD
- NTZ -0.06
- CCEL -0.03
- Stochastic Oscillator
- NTZ 0.00
- CCEL 2.08
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.